Peptidoglycan Suppresses Melanoma Growth in a Murine Model with Local Immune Activation.

Ayaka Ichikawa, Takehisa Nakanishi, Mai Nishimura, Masako Ichishi, Yoshiaki Matsushima, Makoto Kondo, Keiichi Yamanaka

Abstract read

In one paragraph

Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Ayaka IchikawaDepartment of Dermatology, Graduate School of Medicine, Mie University, Tsu 514-8507, Mie, Japan.

Takehisa NakanishiDepartment of Dermatology, Graduate School of Medicine, Mie University, Tsu 514-8507, Mie, Japan.

Mai NishimuraDepartment of Dermatology, Graduate School of Medicine, Mie University, Tsu 514-8507, Mie, Japan.

Masako IchishiDepartment of Oncologic Pathology, Graduate School of Medicine, Mie University, Tsu 514-8507, Mie, Japan.

Yoshiaki MatsushimaDepartment of Dermatology, Graduate School of Medicine, Mie University, Tsu 514-8507, Mie, Japan.ORCID 0000-0001-6114-0830

Makoto KondoDepartment of Dermatology, Graduate School of Medicine, Mie University, Tsu 514-8507, Mie, Japan.ORCID 0000-0003-1560-6067

Keiichi YamanakaDepartment of Dermatology, Graduate School of Medicine, Mie University, Tsu 514-8507, Mie, Japan.ORCID 0000-0003-3055-5202

Funding

Japan Society for the Promotion of Science 25K11582

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Melanoma, ExperimentalPeptidoglycanAnimalsBacterial LysatesCell Line, TumorDisease Models, AnimalFemaleImmunity, InnateLipopolysaccharidesMiceMice, Inbred C57BLTeichoic AcidsToll-Like Receptor 2Tumor Necrosis Factor-alphaBacterial LysatesLipopolysaccharideslipoteichoic acidPeptidoglycanTeichoic AcidsTlr2 protein, mouseToll-Like Receptor 2Tumor Necrosis Factor-alphaCutibacterium acnesinnate immunitylipoteichoic acidmelanomapeptidoglycanToll-like receptor 2type 1-biased immune activation

Identifiers

PMID42883829

DOI10.3390/ijms27198584

PMCPMC13664847

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.